Loading clinical trials...
Loading clinical trials...
The objectives of the intervention are to counteract the progression of cognitive decline, enhance the intrinsic abilities of users and support the well-being of elderly people with mild cognitive imp...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Istituto Nazionale di Ricovero e Cura per Anziani
Collaborators
NCT05877196 · Mild Cognitive Impairment, Alzheimer Disease, and more
NCT07101380 · Mild Cognitive Impairment (MCI)
NCT06121544 · Alzheimer Disease, Mild Cognitive Impairment, and more
NCT06669546 · Cognitive Decline, Alzheimer Disease, and more
NCT03653156 · Mild Cognitive Impairment(MCI), Alzheimer Disease, Late Onset, and more
IRCCS INRCA Hospital
Ancona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions